A Shifty Target: Tumor-Initiating Cells and Their Metabolism

Nicole Bezuidenhout1, Maria Shoshan2

  • 1Department of Oncology-Pathology, Karolinska Institute, 171 64 Stockholm, Sweden. nicole.bezuidenhout@ki.se.

Insights

Tumor-initiating cells (TICs) are chemoresistant cancer stem cells crucial for metastasis. Their unique metabolism, particularly oxidative processes, is key to their function and requires advanced study.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Research

Background:

  • Tumor-initiating cells (TICs), also known as cancer stem cells, are implicated in cancer metastasis and chemoresistance.
  • TICs are identified by sphere formation and specific cell surface markers.
  • While TICs exhibit metabolic plasticity, their metabolic profile differs from bulk tumor cells and varies by tumor type and growth conditions.

Purpose of the Study:

  • To review the association between TIC isolation methods, markers, and metabolic features in common solid tumors.
  • To highlight the role of oxidative metabolism, including fatty acid and lipid metabolism, in TIC phenotypes.
  • To discuss mitochondrial biogenesis, dynamics, and the tumor microenvironment's influence on TICs.

Main Methods:

  • Literature review of studies on TIC isolation, markers, and metabolism.
  • Focus on oxidative metabolism, fatty acid, and lipid metabolism in TICs.
  • Examination of mitochondrial aspects and the tumor microenvironment's impact.

Main Results:

  • TIC isolation methods and markers correlate with distinct metabolic characteristics.
  • Oxidative metabolism, fatty acid, and lipid metabolism are significant factors in TIC phenotypes and overall tumor biology.
  • Mitochondrial function and the tumor microenvironment play crucial roles in TIC biology.

Conclusions:

  • Understanding TIC metabolism is vital for targeting chemoresistant and metastatic cancers.
  • Advanced methodologies are necessary to fully elucidate the complex biology and metabolism of TICs.
  • Metabolic targeting of TICs represents a promising therapeutic strategy.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K